COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.

Also called NCT01752127

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01752127
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01752127. Randomized; single masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2013-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease
Acronym
COPERES
Condition
Angioplasty, Balloon, Coronary
Intervention (Procedure)
percutaneous coronary intervention using drug eluting stent
Lead sponsor
Chonbuk National University Hospital (class: other)

Record details

Record id
cardio:ct-nct01752127
Content hash
9ffd9007455b9735c6fc63a7405874a0830dd80e84622f79f7473bac3f6ef04e